REPRISE III

Investigator: Neal Kleiman, MD

Study Coordinator: LaShawna Green

Status: Enrolling

ClinicalTrials.gov Number: NCT02202434

Phone: 713.441.6548

IRB Number: Pro00011356

Description

The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extreme or high risk for surgical valve replacement.
More to Explore